Compositions, methods and kits relating to poxvirus subunit vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 14, 2009
Grant Date -
Mar 23, 2006
app pub date -
Dec 13, 2004
filing date -
Feb 28, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention is directed to a poxvirus vaccine comprising a soluble truncated poxvirus envelope protein. The invention is also directed to a vaccine comprising a nucleic acid encoding such proteins. Also included is an antibody which specifically binds to the proteins and nucleic acid encoding the same, as well as methods of preventing and treating a poxvirus infection using the afore-mentioned vaccine, antibody, protein, and nucleic acid encoding them.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully